ImmunityBio and Microsoft create 3D model to support Covid-19 research
Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create...
Exscientia forms UK-US partnership to screen possible Covid-19 drugs
Artificial intelligence (AI) drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with...
Noveome studies anti-inflammatory drug ST266 in Covid-19
Next generation biologics company Noveome Biotherapeutics will evaluate its lead programme ST266 as a potential...
J&J partners with BARDA to commit $1bn to Covid-19 vaccine development
Johnson & Johnson (J&J) has expanded its partnership with the US Department for Health and...
UK pledges £210m to CEPI for Covid-19 vaccine development
Non-profit the Coalition for Epidemic Preparedness Innovations (CEPI) has received £210m from the UK Government...
Novavax’s Nanoflu compares well to Fluzone Quadrivalent
US-based Novavax has published top-line Phase III data for its seasonal influenza vaccine Nanoflu in...
Turning pharma green: an eco-wish list for the industry
The reality of climate change is hard to ignore. As one of the biggest polluters,...
Novartis publishes more positive data for Zolgensma
Novartis subsidiary AveXis presented positive, updated data from three clinical trials of its one-dose gene...
Stanford’s StartX joins Covid-19 response with task force
Stanford University non-profit start-up StartX has launched StartX Med Covid-19 task force to mobilise 70...